LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL- Part 2 - Bevacizumab analysis -

Aplikace | 2017 | ShimadzuInstrumentace

LC/MS, LC/MS/MS, LC/QQQ

Zaměření

Klinická analýza

Výrobce

Shimadzu

Přejít do knihovny Zobrazit PDF

PDF verze ke stažení a čtení

Podobná PDF

LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL- Part 2 - Bevacizumab analysis

2017|Shimadzu|Aplikace

LAAN-A-LM-E117A Application News No. C146A nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL- Part 2 - Bevacizumab analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that enables…

Klíčová slova

antibody, bevacizumab, confirmation, structure, quantitation, nsmol, human, mrm, nsmoltm, accuracy, ftfsldtsk, plasma, proteolysis, drug, chromatograms

LC-MS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 5 – Instrument comparison of precision and accuracy –

2018|Shimadzu|Aplikace

LAAN-A-LM-E138 Application News No. C169 nSMOLTM Antibody BA Kit LC-MS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 5 – Instrument comparison of precision and accuracy – nSMOLTM Antibody BA Kit Features Analysis Conditions for Bevacizumab…